Irhythm Technologies (IRTC) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Irhythm Technologies’ decision to engage in capped call transactions in relation to the 2029 Notes could introduce volatility in its common stock value. These transactions aim to mitigate dilution and cash payment impacts upon conversion of the notes, but are limited by a specified cap. The option counterparties may adjust their hedge positions through activities involving Irhythm’s common stock, which could influence stock prices. Such adjustments might occur during observation periods, or when the company undertakes redemptions or repurchases, potentially leading to market price fluctuations of Irhythm’s common stock.
The average IRTC stock price target is $136.67, implying 33.10% upside potential.
To learn more about Irhythm Technologies’ risk factors, click here.
